Viewing StudyNCT00020189



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00020189
Status: COMPLETED
Last Update Posted: 2013-06-19
First Post: 2001-07-11

Brief Title: Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Thromboembolism
Head and Neck Cancer
Keywords:
Name View
stage IV salivary gland cancer View
thromboembolism View
untreated metastatic squamous neck cancer with occult primary View
recurrent metastatic squamous neck cancer with occult primary View
metastatic squamous neck cancer with occult primary squamous cell carcinoma View
stage IV squamous cell carcinoma of the lip and oral cavity View
recurrent squamous cell carcinoma of the lip and oral cavity View
stage IV squamous cell carcinoma of the oropharynx View
recurrent squamous cell carcinoma of the oropharynx View
stage IV squamous cell carcinoma of the hypopharynx View
recurrent squamous cell carcinoma of the hypopharynx View
stage IV squamous cell carcinoma of the larynx View
recurrent squamous cell carcinoma of the larynx View
stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity View
recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity View
recurrent salivary gland cancer View
salivary gland squamous cell carcinoma View